The diabetic foot (DF) is a complex pathology involving the lower limb of 8 to 10 million people around the world, and its prevalence is rising, creating a dramatic need for effective therapeutic answers. The multidisciplinary DF clinic has been proposed as a model to fight this complication from the International Working Group on Diabetic Foot (IWGDF) inside a more articulated 3-level organization strategy. The organization and technical aspects of this strategy, together with the characteristics of each of the 3 levels have been analyzed and described in the article, together with the aims and limitations of each of the levels to cope with a 3-dimensional pathology involving systemic, local, and logistic aspects. The implementation of this model in Europe produced positive results measured so far in at least 2 nationwide experiences, in Germany and in Italy, and it should be taken in account whenever health policies apply to the DF issue.
BoultonAJVileikyteLRagnarson-TennvallGApelqvistJ. The global burden of diabetic foot disease. Lancet. 2005;366:1719-1724.
2.
Ziegler-GrahamKMacKenzieEJEphraimPLTravisonTGBrookmeyerR. Estimating the loss of lower limb in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008;16:422-426.
PecoraroREReiberGEBurgessEM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13:513-521.
5.
MoulikPKMtongaRGillGV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26:481-484.
6.
PrompersLHuijbertsMApelqvistJ. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50:18-25.
7.
ApelqvistJBakkerKvan HoutumWHSchaperNC. International Working Group on the Diabetic Foot (IWGDF) Editorial Board. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2008;24(suppl 1):S181-S187.
8.
ApelqvistJBakkerKvan HoutumWHSchaperNC. International Working Group on the Diabetic Foot (IWGDF) Editorial Board. The development of global consensus guidelines on the management of the diabetic foot. Diabetes Metab Res Rev. 2008;24(suppl 1):S116-S118.
9.
BoultonAJ. The pathway to foot ulceration in diabetes. Med Clin North Am. 2013;97:775-790.
10.
ApelqvistJElgzyriTLarssonJLöndahlMNybergPThörneJ. Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. J Vasc Surg. 2011;53:1582.e2-1588.e2.
11.
JacobsonAMBraffettBHClearyPAGubitosi-KlugRALarkinME, DCCT/EDIC Research Group. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort. Diabetes Care. 2013;36:3131-3138.
12.
FagliaEClericiGCaminitiMQuarantielloAGinoMMorabitoA. The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes. J Foot Ankle Surg. 2006;45:220-226.
13.
RizzoLTedeschiAFallaniECoppelliAValliniVIacopiEPiaggesiA. Custom-made orthesis and shoes in a structured follow-up program reduces the incidence of neuropathic ulcers in high-risk diabetic foot patients. Int J Low Extrem Wounds. 2012;11:59-64.
14.
van AckerKLégerPHartemannAChawlaASiddiquiMK. Burden of diabetic foot disorders, guidelines for management, and disparities in implementation in Europe: a systematic literature review [published online January27, 2014]. Diabetes Metab Res Rev. doi:10.1002/dmrr.2523.
15.
DubskýM1JirkovskáABemR. Risk factors for recurrence of diabetic foot ulcers: prospective follow-up analysis in the Eurodiale subgroup. Int Wound J. 2013;10:555-561.
16.
PetreMTokarPKostarDCavanaghPR. Revisiting the total contact cast: maximizing off-loading by wound isolation. Diabetes Care. 2005;28:929-930.
17.
BraunLRFiskWALev-TovHKirsnerRSIsseroffRR. Diabetic foot ulcer: an evidence-based treatment update [published online June6, 2014]. Am J Clin Dermatol. doi:10.1007/s40257-014-0081-9.
18.
BusSAWaaijmanRArtsM. Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care. 2013;36:4109-4116.
19.
DahmenRHaspelsRKoomenBHoeksmaAF. Therapeutic footwear for the neuropathic foot: an algorithm. Diabetes Care. 2001;24:705-709.
20.
ScatenaAPetruzziPFerrariM. Outcomes of three years of teamwork on critical limb ischemia in patients with diabetes and foot lesions. Int J Low Extrem Wounds. 2012;11:113-119.
21.
ZampaVBargelliniIRizzoL. Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus. Skeletal Radiol. 2011;40:991-999.
JainN. Build teams to run marathons, not sprints. In: DavisBTuckerH, eds. 97 Things Every Project Manager Should Know: Collective Wisdom from the Experts. Sebastopol, CA: O’Reilly Media; 2009:96-98.
24.
AielloAAnichiniRBroccoE. Treatment of peripheral arterial disease in diabetes: a consensus of the Italian Societies of Diabetes (SID, AMD), Radiology (SIRM) and Vascular Endovascular Surgery (SICVE). Nutr Metab Cardiovasc Dis. 2014;24:355-369.
25.
FagliaEClericiGCaminitiMQuarantielloAGinoMMorabitoA. The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes. J Foot Ankle Surg. 2006;45:220-226.
26.
RümenapfGDentzJNagelNMorbachS. Neue Konzepte zur interdisziplinären Versorgung von Patienten mit neuroischämischem diabetischem Fußsyndrom (DFS). Gefässchirurgie. 2012;17:327-333.
27.
LobmannRAchwerdovOBrunk-LochSEngelsGTrochaAGroeneKKerskenJ. The diabetic foot in Germany 2005–2012: analysis of quality in specialized diabetic foot care centers. Wound Med. 2014;4:27-29.
28.
LombardoFLMagginiMDe BellisASeghieriGAnichiniR. Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010. PLoS One. 2014;9:e86405.
